Chapter 2. Scientific and Medical Accountability Standards
- § 100010. Scope of Chapter 2 — Stem Cell Research.
- § 100020. Definitions.
- § 100030. Activities Not Eligible for CIRM Funding.
- § 100040. Awardee Assurance of Compliance.
- § 100050. Compliance.
- § 100060. SCRO Committee Membership and Function.
- § 100070. SCRO Committee Review and Notification.
- § 100080. Acceptable Research Materials.
- § 100081. Exemption Petition for Lines Derived Prior to November 22, 2006.
- Appendix A
- § 100085. Use of Fetal Tissue.
- § 100090. Special Considerations for CIRM-Funded Procurement, Derivation and Transplantation.
- § 100095. Additional Requirements for CIRM-Funded Research Involving Oocytes.
- § 100100. Informed Consent Requirements.
- § 100110. Fairness and Diversity in Research.
- § 100120. Record Keeping.
- § 100140. Scope of Chapter. [Repealed]
- § 100141. Categories of Hes Cell Research. [Repealed]
- § 100142. Hes Cell Research Eligible for CIRM Funding. [Repealed]
- § 100143. Hes Cell Research Eligible for CIRM Funding After Additional Escro Review and Approval. [Repealed]
- § 100144. Hes Cell Research that is Prohibited. [Repealed]
- § 100145. Obligations of Investigators and Institutions. [Repealed]
- § 100146. Establishment of an Institutional Embryonic Stem Cell Research Oversight Committee. [Repealed]
- § 100147. Procurement of Gametes, Blastocysts or Cells for Hes Generation. [Repealed]
- § 100148. Derivation of Hes Cell Lines. [Repealed]
- § 100149. Banking and Distribution of Hes Cell Lines. [Repealed]
- § 100150. Research Use of Hes Cell Lines. [Repealed]
- § 100300. Intellectual Property Requirements for Non-Profit Organizations — Scope.
- § 100301. Intellectual Property Regulations — Definitions.
- § 100302. Invention Reporting Requirements.
- § 100303. Publication Requirements.
- § 100304. Biomedical Materials.
- § 100305. Patent Applications.
- § 100306. Licensing CIRM-Funded Patented Inventions.
- § 100308. Revenue Sharing.
- § 100309. Press Release Requirements.
- § 100310. March-in Rights.